Segment Information (Tables)
|
12 Months Ended |
Dec. 31, 2014 |
Segment Reporting, Measurement Disclosures [Abstract] |
|
Segment Results |
Detailed segment data for the years ended December 31 is as follows ($ in millions): | | | | | | | | | | | | | | 2014 | | 2013 | | 2012 | Sales: | | | | | | Test & Measurement | $ | 2,702.1 |
| | $ | 2,582.4 |
| | $ | 2,595.4 |
| Environmental | 3,547.3 |
| | 3,316.9 |
| | 3,063.5 |
| Life Sciences & Diagnostics | 7,185.7 |
| | 6,856.4 |
| | 6,485.1 |
| Dental | 2,193.1 |
| | 2,094.9 |
| | 2,022.9 |
| Industrial Technologies | 3,525.8 |
| | 3,432.5 |
| | 3,307.9 |
| Total | $ | 19,154.0 |
| | $ | 18,283.1 |
| | $ | 17,474.8 |
| | | | | | | Operating profit: | | | | | | Test & Measurement | $ | 573.2 |
| | $ | 515.1 |
| | $ | 515.7 |
| Environmental | 705.2 |
| | 696.5 |
| | 652.5 |
| Life Sciences & Diagnostics | 1,105.9 |
| | 1,009.8 |
| | 861.1 |
| Dental | 304.4 |
| | 304.9 |
| | 293.1 |
| Industrial Technologies | 801.3 |
| | 722.9 |
| | 685.6 |
| Equity method earnings related to Apex joint venture | — |
| | — |
| | 69.9 |
| Other | (143.4 | ) | | (128.7 | ) | | (98.3 | ) | Total | $ | 3,346.6 |
| | $ | 3,120.5 |
| | $ | 2,979.6 |
| | | | | | | Identifiable assets: | | | | | | Test & Measurement | $ | 3,550.9 |
| | $ | 3,561.6 |
| | $ | 3,619.5 |
| Environmental | 3,824.9 |
| | 3,584.5 |
| | 3,146.6 |
| Life Sciences & Diagnostics | 13,743.9 |
| | 13,614.7 |
| | 13,305.2 |
| Dental | 6,224.3 |
| | 4,095.1 |
| | 4,079.9 |
| Industrial Technologies | 4,149.0 |
| | 4,363.6 |
| | 4,235.6 |
| Other | 3,615.2 |
| | 3,519.3 |
| | 2,667.9 |
| Discontinued Operations | 1,883.5 |
| | 1,933.4 |
| | 1,886.3 |
| Total | $ | 36,991.7 |
| | $ | 34,672.2 |
| | $ | 32,941.0 |
| | | | | | | Depreciation and amortization: | | | | | | Test & Measurement | $ | 83.5 |
| | $ | 90.7 |
| | $ | 91.5 |
| Environmental | 85.7 |
| | 62.7 |
| | 48.9 |
| Life Sciences & Diagnostics | 539.0 |
| | 517.3 |
| | 478.2 |
| Dental | 85.0 |
| | 83.3 |
| | 92.4 |
| Industrial Technologies | 88.8 |
| | 89.2 |
| | 80.8 |
| Other | 7.5 |
| | 7.4 |
| | 7.2 |
| Total | $ | 889.5 |
| | $ | 850.6 |
| | $ | 799.0 |
|
| | | | | | | | | | | | | | 2014 | | 2013 | | 2012 | Capital expenditures, gross: | | | | | | Test & Measurement | $ | 17.0 |
| | $ | 25.4 |
| | $ | 25.0 |
| Environmental | 76.1 |
| | 46.5 |
| | 29.5 |
| Life Sciences & Diagnostics | 391.1 |
| | 386.7 |
| | 296.8 |
| Dental | 24.4 |
| | 30.7 |
| | 30.2 |
| Industrial Technologies | 70.6 |
| | 47.1 |
| | 49.0 |
| Other | 1.4 |
| | 1.7 |
| | 15.3 |
| Total | $ | 580.6 |
| | $ | 538.1 |
| | $ | 445.8 |
|
|
Schedule Of Operations In Geographical Areas |
Operations in Geographical Areas Year Ended December 31 | | | | | | | | | | | | | ($ in millions) | 2014 | | 2013 | | 2012 | Sales: | | | | | | United States | $ | 8,091.2 |
| | $ | 7,613.6 |
| | $ | 7,353.7 |
| China | 1,727.5 |
| | 1,612.7 |
| | 1,424.7 |
| Germany | 1,182.9 |
| | 1,161.5 |
| | 1,085.8 |
| All other (each country individually less than 5% of total sales) | 8,152.4 |
| | 7,895.3 |
| | 7,610.6 |
| Total | $ | 19,154.0 |
| | $ | 18,283.1 |
| | $ | 17,474.8 |
| | | | | | | Long-lived assets: | | | | | | United States | $ | 16,888.3 |
| | $ | 15,673.7 |
| | $ | 15,980.8 |
| Germany | 1,875.1 |
| | 1,939.7 |
| | 1,957.1 |
| All other (each country individually less than 5% of total long-lived assets) | 8,797.0 |
| | 7,945.1 |
| | 7,415.3 |
| Total | $ | 27,560.4 |
| | $ | 25,558.5 |
| | $ | 25,353.2 |
|
|
Sales By Major Product Group |
Sales by Major Product Group Year Ended December 31 | | | | | | | | | | | | | ($ in millions) | 2014 | | 2013 | | 2012 | Analytical & physical instrumentation | $ | 5,778.6 |
| | $ | 5,443.6 |
| | $ | 5,215.2 |
| Medical & dental products | 9,381.6 |
| | 8,958.0 |
| | 8,509.1 |
| Motion & industrial automation controls | 1,554.5 |
| | 1,559.1 |
| | 1,592.4 |
| Product identification | 1,611.2 |
| | 1,551.5 |
| | 1,410.3 |
| All other | 828.1 |
| | 770.9 |
| | 747.8 |
| Total | $ | 19,154.0 |
| | $ | 18,283.1 |
| | $ | 17,474.8 |
|
|